Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced/metastatic biliary tract carcinoma.

Jae Yong Cho; Yong Han Paik; Yoon Soo Chang; Se Joon Lee; Dong-Ki Lee; Si Young Song; Jae Bock Chung; Mi-Suk Park; Jeong-Sik Yu; Dong-Sup Yoon

doi:10.1002/cncr.21591

Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced/metastatic biliary tract carcinoma.

Identifier:nobleid.org/w1/20260515/39CB52C2

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/39CB52C2.svg?ark=w1%2F20260515%2F39CB52C2)](https://nobleid.org/work/w1/20260515/39CB52C2)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced/metastatic biliary tract carcinoma.

Identifier:nobleid.org/w1/20260515/39CB52C2

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/39CB52C2.svg?ark=w1%2F20260515%2F39CB52C2)](https://nobleid.org/work/w1/20260515/39CB52C2)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work